BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35718359)

  • 21. Vasopressin receptor mutations in nephrogenic diabetes insipidus.
    Bichet DG
    Semin Nephrol; 2008 May; 28(3):245-51. PubMed ID: 18519085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus.
    van Os CH; Deen PM
    Proc Assoc Am Physicians; 1998; 110(5):395-400. PubMed ID: 9756089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic Fanconi's syndrome with nephrogenic diabetes insipidus in a child who presented as vitamin D resistant rickets--a case report and review of literature.
    Patra S; Nadri G; Chowdhary H; Pemde HK; Singh V; Chandra J
    J Pediatr Endocrinol Metab; 2011; 24(9-10):755-7. PubMed ID: 22145469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and genetic features in autosomal recessive and X-linked Alport syndrome.
    Wang Y; Sivakumar V; Mohammad M; Colville D; Storey H; Flinter F; Dagher H; Savige J
    Pediatr Nephrol; 2014 Mar; 29(3):391-6. PubMed ID: 24178893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital nephrogenic diabetes insipidus with end-stage renal disease.
    Ryu HH; Chung JH; Shin BC; Kim HL
    Korean J Intern Med; 2015 Mar; 30(2):259-61. PubMed ID: 25750571
    [No Abstract]   [Full Text] [Related]  

  • 26. Hereditary Renal Diseases.
    Mehta L; Jim B
    Semin Nephrol; 2017 Jul; 37(4):354-361. PubMed ID: 28711074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome.
    Shaw EA; Colville D; Wang YY; Zhang KW; Dagher H; Fassett R; Guymer R; Savige J
    Nephrol Dial Transplant; 2007 Jan; 22(1):104-8. PubMed ID: 17071739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular biological studies on patients with nephrogenic diabetes insipidus].
    Szalai C; Molnár E; Sallay P; Czinner A
    Orv Hetil; 1998 Apr; 139(15):883-7. PubMed ID: 9579101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of mutations in the COL4A5 collagen gene in Alport syndrome.
    Barker DF; Hostikka SL; Zhou J; Chow LT; Oliphant AR; Gerken SC; Gregory MC; Skolnick MH; Atkin CL; Tryggvason K
    Science; 1990 Jun; 248(4960):1224-7. PubMed ID: 2349482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.
    Jais JP; Knebelmann B; Giatras I; Marchi M; Rizzoni G; Renieri A; Weber M; Gross O; Netzer KO; Flinter F; Pirson Y; Verellen C; Wieslander J; Persson U; Tryggvason K; Martin P; Hertz JM; Schröder C; Sanak M; Krejcova S; Carvalho MF; Saus J; Antignac C; Smeets H; Gubler MC
    J Am Soc Nephrol; 2000 Apr; 11(4):649-657. PubMed ID: 10752524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of Alport syndrome.
    Tryggvason K; Zhou J; Hostikka SL; Shows TB
    Kidney Int; 1993 Jan; 43(1):38-44. PubMed ID: 8433568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4).
    Jefferson JA; Lemmink HH; Hughes AE; Hill CM; Smeets HJ; Doherty CC; Maxwell AP
    Nephrol Dial Transplant; 1997 Aug; 12(8):1595-9. PubMed ID: 9269635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.
    García Castaño A; Pérez de Nanclares G; Madariaga L; Aguirre M; Chocron S; Madrid A; Lafita Tejedor FJ; Gil Campos M; Sánchez Del Pozo J; Ruiz Cano R; Espino M; Gomez Vida JM; Santos F; García Nieto VM; Loza R; Rodríguez LM; Hidalgo Barquero E; Printza N; Camacho JA; Castaño L; Ariceta G;
    Eur J Pediatr; 2015 Oct; 174(10):1373-85. PubMed ID: 25902753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular genetics of Alport syndrome].
    Yamazaki H; Saito A; Nakagawa Y; Arakawa M
    Nihon Rinsho; 1992 Dec; 50(12):3021-6. PubMed ID: 1491454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
    Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
    Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case report of nephrogenic diabetes insipidus with idiopathic Fanconi syndrome in a child who presented with vitamin D resistant rickets.
    Patra S; Nadri G; Chowdhary H; Pemde HK; Singh V; Chandra J
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):573-5. PubMed ID: 24821875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report.
    Hao W; Ao L; Zhang C; Zhu L; Xie D
    J Int Med Res; 2020 Mar; 48(3):300060519891290. PubMed ID: 31840555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Living donor kidney transplantation in patients with hereditary nephropathies.
    Niaudet P
    Nat Rev Nephrol; 2010 Dec; 6(12):736-43. PubMed ID: 20877305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
    Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
    Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X chromosome inactivation patterns in normal and X-linked hereditary nephropathy carrier dogs.
    Bell RJ; Lees GE; Murphy KE
    Cytogenet Genome Res; 2008; 122(1):37-40. PubMed ID: 18931484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.